This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Alan Meyers, MD, MPH
Division of General Pediatrics Boston City Hospital 818 Harrison Ave Boston, MA 02118

Arch Pediatr Adolesc Med. 1995;149(8):930.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Bye and coworkers¹ have provided extremely valuable data on the efficacy of corticosteroid therapy in treating Pneumocystis carinii pneumonia (PCP) in children infected with human immunodeficiency virus. However, I believe that some of the statistical analyses shown in their Table are incorrect and that the errors have influenced some of their conclusions. Using their data, I performed ² analysis using Epi Info, Version 5,² the statistical software package distributed by the Centers for Disease Control and Prevention, Atlanta, Ga. The results are shown in the Table.

This reanalysis shows that there is not a significant difference in the incidence of adverse reactions to a combination of trimethoprim and sulfamethoxazole between the two groups or a difference in the proportion of patients who presented with PCP as the initial manifestation of human immunodeficiency virus infection. The reduction in the proportion of patients requiring mechanical ventilation is of marginal . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?